Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

A Validation Study of Administrative Health Care Data to Detect Acute Kidney Injury in the Pediatric Intensive Care Unit.

D'Arienzo D, Hessey E, Ali R, Perreault S, Samuel S, Roy L, Lacroix J, Jouvet P, Morissette G, Dorais M, Lafrance JP, Phan V, Pizzi M, Chanchlani R, Zappitelli M.

Can J Kidney Health Dis. 2019 Feb 10;6:2054358119827525. doi: 10.1177/2054358119827525. eCollection 2019.

2.

Study of the bioaccumulation of tinzaparin in renally impaired patients when given at prophylactic doses - The STRIP study.

Projean D, Lalonde S, Morin J, Nogues E, Séguin A, Vincent A, Lafrance JP, Masson V, Kassis J, Fafard J, Lordkipanidzé M.

Thromb Res. 2019 Feb;174:48-50. doi: 10.1016/j.thromres.2018.11.031. Epub 2018 Dec 2. No abstract available.

PMID:
30554045
3.

Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study.

Lazrak HH, René E, Elftouh N, Lafrance JP.

Can J Kidney Health Dis. 2018 Aug 2;5:2054358118792010. doi: 10.1177/2054358118792010. eCollection 2018.

4.

Hospitalizations in Dialysis Patients in Canada: A National Cohort Study.

Molnar AO, Moist L, Klarenbach S, Lafrance JP, Kim SJ, Tennankore K, Perl J, Kappel J, Terner M, Gill J, Sood MM.

Can J Kidney Health Dis. 2018 Jun 1;5:2054358118780372. doi: 10.1177/2054358118780372. eCollection 2018.

5.

Semantics and medical assistance in dying.

Lafrance JR.

CMAJ. 2018 Jun 11;190(23):E727. doi: 10.1503/cmaj.69277. No abstract available.

PMID:
29891480
6.

Long-term Mortality After Acute Kidney Injury in the Pediatric ICU.

Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Jouvet P, Lafrance JP, LeLorier J, Phan V, Palijan A, Pizzi M, Roy L, Zappitelli M.

Hosp Pediatr. 2018 May;8(5):260-268. doi: 10.1542/hpeds.2017-0215.

PMID:
29712717
7.

Healthcare Utilization after Acute Kidney Injury in the Pediatric Intensive Care Unit.

Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Phan V, Jouvet P, Lafrance JP, LeLorier J, Palijan A, Pizzi M, Roy L, Zappitelli M.

Clin J Am Soc Nephrol. 2018 May 7;13(5):685-692. doi: 10.2215/CJN.09350817. Epub 2018 Apr 20.

PMID:
29678895
8.

Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients.

Pineault J, Lamarche C, Bell R, Lafrance JP, Ouellet G, Leblanc M, Pichette V, Bezzaoucha S, Vallée M.

Can J Kidney Health Dis. 2017 Nov 3;4:2054358117735563. doi: 10.1177/2054358117735563. eCollection 2017.

9.

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.

Lazrak HH, René É, Elftouh N, Leblanc M, Lafrance JP.

BMC Nephrol. 2017 Jun 7;18(1):187. doi: 10.1186/s12882-017-0596-4. Review.

10.

Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies.

Kuate Defo B, Mbanya JC, Tardif JC, Ekundayo O, Perreault S, Potvin L, Cote R, Kengne AP, Choukem SP, Assah F, Kingue S, Richard L, Pongou R, Frohlich K, Saji J, Fournier P, Sobngwi E, Ridde V, Dubé MP, De Denus S, Mbacham W, Lafrance JP, Nsagha DS, Mampuya W, Dzudie A, Cloutier L, Zarowsky C, Tanya A, Ndom P, Hatem M, Rey E, Roy L, Borgès Da Silva R, Dagenais C, Todem D, Weladji R, Mbanya D, Emami E, Njoumemi Z, Monnais L, Dubois CA.

JMIR Res Protoc. 2017 May 29;6(5):e102. doi: 10.2196/resprot.7807.

11.

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation.

Mawad H, Bouchard H, Tran D, Ouimet D, Lafrance JP, Bell RZ, Bezzaoucha S, Boucher A, Collette S, Pichette V, Senécal L, Vallée M.

J Transplant. 2017;2017:8720283. doi: 10.1155/2017/8720283. Epub 2017 Mar 13.

12.

Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.

Rauscher S, Lafrance JP, Pichette V, Bell RZ, Desforges K, Lepage L, Ouellet G, Ouimet D, Leblanc M, Lamarche C, Bezzaoucha S, Vallee M.

Int Urol Nephrol. 2017 Feb;49(2):325-328. doi: 10.1007/s11255-016-1446-1. Epub 2016 Nov 8.

PMID:
27822674
13.

New drugs to prevent and treat hyperkalemia.

Lepage L, Desforges K, Lafrance JP.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):524-528. Review.

PMID:
27584929
14.

Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case-control study.

René É, Lazrak HH, Laurin LP, Elftouh N, Vallée M, Lafrance JP.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1047-1052. doi: 10.1093/ndt/gfw268.

PMID:
27448671
15.

Quadracel: Vaccination Against Diphtheria, Tetanus, Pertussis, and Poliomyelitis in Children.

Mosley JF 2nd, Smith LL, Parke CK, Brown JA, LaFrance JM, Clark PK.

P T. 2016 Apr;41(4):238-53.

16.

Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.

Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17.

17.

Efficacy of calcitriol compared to alfacalcidol for the treatment of secondary hyperparathyroidism in peritoneal dialysis patients.

Bezzaoucha S, Lafrance JP, Ouimet D, Pichette V, Bell R, Lamarche C, Vallée M.

Int J Clin Pharmacol Ther. 2015 Oct;53(10):895-6. doi: 10.5414/CP202430. No abstract available.

PMID:
26308178
18.

Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.

Renoux C, Lix LM, Patenaude V, Bresee LC, Paterson JM, Lafrance JP, Tamim H, Mahmud SM, Alsabbagh MW, Hemmelgarn B, Dormuth CR, Ernst P; Canadian Network of Observational Drug Effect Studies (CNODES) Investigators.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1716-22. doi: 10.2215/CJN.11271114. Epub 2015 Jul 31.

19.

Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case-control study.

Harrak H, Normand I, Grinker R, Elftouh N, Laurin LP, Lafrance JP.

BMC Nephrol. 2015 Jul 28;16:115. doi: 10.1186/s12882-015-0112-7.

20.

The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D.

Beaubien-Souligny W, Bezzaoucha S, Pichette V, Lafrance JP, Bell R, Lamarche C, Ouimet D, Vallee M.

Int Urol Nephrol. 2015 Jul;47(7):1165-71. doi: 10.1007/s11255-015-1003-3. Epub 2015 May 17.

PMID:
25982583
21.

Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.

Tseng CL, Lafrance JP, Lu SE, Soroka O, Miller DR, Maney M, Pogach LM.

BMC Nephrol. 2015 Mar 25;16:34. doi: 10.1186/s12882-015-0025-5.

22.

Outcomes of Infection-Related Hospitalization according to Dialysis Modality.

Laurin LP, Harrak H, Elftouh N, Ouimet D, Vallée M, Lafrance JP.

Clin J Am Soc Nephrol. 2015 May 7;10(5):817-24. doi: 10.2215/CJN.09210914. Epub 2015 Mar 27.

23.

An unusual initial presentation of lupus nephritis as a renal mass.

Goupil R, Nadeau-Fredette AC, Royal V, Dugas A, Lafrance JP.

Case Rep Nephrol. 2015;2015:231974. doi: 10.1155/2015/231974. Epub 2015 Jan 8.

24.

Trends in infection-related hospital admissions and impact of length of time on dialysis among patients on long-term dialysis: a retrospective cohort study.

Lafrance JP, Rahme E, Iqbal S, Elftouh N, Laurin LP, Vallée M.

CMAJ Open. 2014 May 23;2(2):E109-14. doi: 10.9778/cmajo.20120027. eCollection 2014 Apr.

25.

French translation and validation of the Readiness for Interprofessional Learning Scale (RIPLS) in a Canadian undergraduate healthcare student context.

Cloutier J, Lafrance J, Michallet B, Marcoux L, Cloutier F.

J Interprof Care. 2015 Mar;29(2):150-5. doi: 10.3109/13561820.2014.942837. Epub 2014 Jul 30.

PMID:
25076020
26.

Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.

Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A.

Exp Clin Transplant. 2014 Aug;12(4):323-7. doi: 10.6002/ect.2013.0165. Epub 2014 May 19. Review.

27.

Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients.

Lessard M, Ouimet D, Leblanc M, Nadeau-Fredette AC, Bell R, Lafrance JP, Pichette V, Vallée M.

BMC Nephrol. 2014 Feb 4;15:27. doi: 10.1186/1471-2369-15-27.

28.

Association between vitamin D receptor activator and the risk of infection-related hospitalizations among incident hemodialysis patients: a nested case-control study.

Normand I, Elftouh N, Laurin LP, Ouimet D, Harrak H, Lafrance JP.

Pharmacoepidemiol Drug Saf. 2014 Mar;23(3):261-7. doi: 10.1002/pds.3576. Epub 2014 Jan 27.

PMID:
24470433
29.

Hemodialysis effects on phenytoin pharmacokinetics.

Bezzaoucha S, Merghoub A, Lamarche C, Pichette V, Lafrance JP, Laurin LP, Vallée M, Robitaille R, Leblanc M, Bell R.

Eur J Clin Pharmacol. 2014 Apr;70(4):499-500. doi: 10.1007/s00228-013-1628-z. Epub 2014 Jan 4. No abstract available.

PMID:
24390629
30.

Canadian Journal of Kidney Health and Disease: a unique launch of a unique journal.

Levin A, Clase CM, Sood MM, Dicks E, Fortin MC, Hartwig S, Holden R, Lafrance JP, Molzahn A, Rosenblum N, Samuel S, Soroka S.

Can J Kidney Health Dis. 2014 Apr 7;1:1. doi: 10.1186/2054-3581-1-1. eCollection 2014.

31.

The role of sevelamer carbonate in increasing serum bicarbonate in hyperphosphatemic predialysis patients who have metabolic acidosis.

Bezzaoucha S, Pichette V, Lafrance JP, Bell R, Laurin LP, Vallée M.

Int J Clin Pharmacol Ther. 2013 Dec;51(12):989-90. doi: 10.5414/CP201941. No abstract available.

PMID:
24075095
32.

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends.

Lafrance JP, Cardinal H, Leblanc M, Madore F, Pichette V, Roy L, Le Lorier J.

BMC Nephrol. 2013 May 3;14:100. doi: 10.1186/1471-2369-14-100.

33.

Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients.

Lafrance JP, Rahme E, Iqbal S, Leblanc M, Pichette V, Elftouh N, Vallée M.

BMC Med Res Methodol. 2013 Mar 27;13:51. doi: 10.1186/1471-2288-13-51.

34.

Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

James M, Bouchard J, Ho J, Klarenbach S, LaFrance JP, Rigatto C, Wald R, Zappitelli M, Pannu N.

Am J Kidney Dis. 2013 May;61(5):673-85. doi: 10.1053/j.ajkd.2013.02.350. Epub 2013 Mar 19. Review. No abstract available.

PMID:
23518195
35.

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.

Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P; Canadian Network for Observational Drug Effect Studies.

BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.

36.

Defining AKI: closer to getting the math right.

Lafrance JP, Levin A.

Nephrol Dial Transplant. 2013 Jun;28(6):1340-2. doi: 10.1093/ndt/gft011. Epub 2013 Mar 10. No abstract available.

PMID:
23479094
37.

Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis.

Lafrance JP, Rahme E, Iqbal S, Elftouh N, Vallée M, Laurin LP, Ouimet D.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1598-605. doi: 10.2215/CJN.00440112. Epub 2012 Aug 16.

38.

Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study.

Clark E, Wald R, Levin A, Bouchard J, Adhikari NK, Hladunewich M, Richardson RM, James MT, Walsh MW, House AA, Moist L, Stollery DE, Burns KE, Friedrich JO, Barton J, Lafrance JP, Pannu N, Bagshaw SM; Canadian Acute Kidney Injury (CANAKI) Investigators.

Can J Anaesth. 2012 Sep;59(9):861-70. doi: 10.1007/s12630-012-9750-4. Epub 2012 Jun 30.

PMID:
22752716
39.

Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.

Lafrance JP, Miller DR.

Am J Kidney Dis. 2012 Jul;60(1):82-9. doi: 10.1053/j.ajkd.2012.02.328. Epub 2012 Apr 12.

PMID:
22503390
40.

Concordance with guideline recommendations: previous and more recent nonsteroidal anti-inflammatory drug prescriptions in Quebec, Canada.

Rahme E, Roussy JP, Lafrance JP, Nedjar H, Morin S.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):420-7. doi: 10.1002/pds.2339. Epub 2012 Jan 4.

PMID:
22223535
41.

Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey.

Faulkner GE, Grootendorst P, Nguyen VH, Andreyeva T, Arbour-Nicitopoulos K, Auld MC, Cash SB, Cawley J, Donnelly P, Drewnowski A, Dubé L, Ferrence R, Janssen I, Lafrance J, Lakdawalla D, Mendelsen R, Powell LM, Traill WB, Windmeijer F.

Int J Behav Nutr Phys Act. 2011 Oct 6;8:109. doi: 10.1186/1479-5868-8-109. Review.

42.

Trends in initial lower extremity amputation rates among Veterans Health Administration health care System users from 2000 to 2004.

Tseng CL, Rajan M, Miller DR, Lafrance JP, Pogach L.

Diabetes Care. 2011 May;34(5):1157-63. doi: 10.2337/dc10-1775. Epub 2011 Mar 16.

43.

Use of nonsteroidal antiinflammatory drugs: is there a change in patient risk profile after withdrawal of rofecoxib?

Rahme E, Roussy JP, Lafrance JP, Nedjar H, Morin S.

J Rheumatol. 2011 Feb;38(2):195-202. doi: 10.3899/jrheum.100332. Epub 2010 Nov 15. Review.

PMID:
21078717
44.

Depression and incident lower limb amputations in veterans with diabetes.

Williams LH, Miller DR, Fincke G, Lafrance JP, Etzioni R, Maynard C, Raugi GJ, Reiber GE.

J Diabetes Complications. 2011 May-Jun;25(3):175-82. doi: 10.1016/j.jdiacomp.2010.07.002. Epub 2010 Aug 30.

45.

Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status.

Lafrance JP, Miller DR.

Am J Kidney Dis. 2010 Oct;56(4):651-60. doi: 10.1053/j.ajkd.2010.05.011. Epub 2010 Jul 29.

PMID:
20673605
46.

Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort.

Lafrance JP, Djurdjev O, Levin A.

Nephrol Dial Transplant. 2010 Jul;25(7):2203-9. doi: 10.1093/ndt/gfq011. Epub 2010 Feb 2.

PMID:
20124548
47.

Acute kidney injury associates with increased long-term mortality.

Lafrance JP, Miller DR.

J Am Soc Nephrol. 2010 Feb;21(2):345-52. doi: 10.1681/ASN.2009060636. Epub 2009 Dec 17.

48.

Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors.

Lafrance JP, Iqbal S, Lelorier J, Dasgupta K, Ritchie J, Ward L, Benaroya S, Barré P, Cantarovich M, Ghannoum M, Proulx N, Vasilevsky M, Rahme E.

Nephron Clin Pract. 2010;114(3):c204-12. doi: 10.1159/000262303. Epub 2009 Nov 28.

PMID:
19955826
49.
50.

Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.

Lafrance JP, Miller DR.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):923-31. doi: 10.1002/pds.1798.

PMID:
19585463

Supplemental Content

Loading ...
Support Center